SeerPharma Pty Ltd :: DISCover web-based training

Prostate Cancer: Treatment

Description: In the U.S., prostate cancer is the most commonly diagnosed and the second most common cause of cancer death in men. The incidence of prostate cancer is increasing at an average rate of 3% a year. This course explains the different factors involved in determination of a prognosis and the various treatment options for prostate cancer.

COURSE OUTLINE

INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PROGNOSIS
4. Objectives
5. Histological Grading
6. Imaging
7. Pathological Indicators
8. Molecular and Cellular Markers
9. Progress Check

TREATMENT
10. Objectives
11. Quality of Life
12. Watchful Waiting
13. Surgery
14. EBRT
15. Prostate Brachytherapy
16. Chemotherapy
17. LHRH Analogs
18. Anti-Androgens
19. Androgen Blockade
20. Progress Check

CASE STUDIES
21. Early Stage (Localized)
22. Locally Advanced Disease
23. Advanced Disease
24. Hormone-Refractory Disease

CONCLUSION
25. Summary

COURSE OBJECTIVES

Students completing this course should be able to:

Correlate Gleason grade and PSA level with prognosis
Understand how imaging techniques contribute to determination of prognosis
List pathological indicators of prognosis
Be familiar with molecular and cellular prognostic markers
List factors involved in making quality of life treatment decisions
Explain when and where surgery should be used
Describe the use of radiotherapy as both a palliative and curative tool
List the types of chemical agents used in chemotherapy
Explore diagnostic options given a particular case history
List available treatment options for localized prostate cancer
Explain why continual monitoring of the patient is necessary
Explain when hormonal therapy may be used in locally advanced non-metastastic disease
List what factors should be considered when anti-androgens are used
Explore the appropriate diagnostic investigations for advanced prostate cancer
Explain how anti-androgens are thought to work
List advantages of anti-androgens over LHRH analogs
List common near-terminal events accompanying prostate cancer
Describe the purpose of treatment in advanced disease

Home

Training Programs

Upcoming Training

Compliance Consulting

DISCover e-Learning

Modules available

SOPtrain

Quality Management Software

Clinical Trials Software

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.